Table 2.
Patient characteristics. All values are either median (IQR) or frequency (proportion).
| n = 2,849 | |
|---|---|
| Age at Surgery, yrs | 60 (55, 65) |
| BMI, kg/m2 | 28 (25, 30) |
| PSA, ng/ml | 5 (4, 7) |
| History of TURP | 38 (1%) |
| Clinical Stage | |
| ≤T1C | 1,873 (66%) |
| T2A | 495 (17%) |
| ≥T2B | 481 (17%) |
| Biopsy Gleason Score | |
| ≤6 | 1,487 (52%) |
| 7 | 1,141 (40%) |
| ≥8 | 221 (8%) |
| ASA Score | |
| I/II | 2,350 (82%) |
| III/IV | 499 (18%) |
| Comorbidities | |
| 0 | 1,146 (40%) |
| 1 | 1,017 (36%) |
| 2 | 528 (19%) |
| 3+ | 158 (6%) |
| Nerve-Sparing Status | |
| Both preserved | 2,130 (75%) |
| Unilateral preservation | 447 (15%) |
| Both resected | 272 (10%) |
| Year of Surgery | |
| 2001–2005 | 940 (33%) |
| 2006–2010 | 1,909 (67%) |
| Surgical Approach | |
| Open | 1,487 (52%) |
| Laparoscopic | 931 (33%) |
| Robotic | 431 (15%) |
| Continence Outcomes | |
| Continent at 6 months, n=2,559 | 1,742 (68%) |
| Continent at 12 months, n=2,689 | 2,205 (82%) |